Elevated cyclic AMP suppresses ConA-induced MT1-MMP expression in MDA- MB-231 human breast cancer cells

Clinical and Experimental Metastasis

Volumn 16, Issue 2, 1998, Pages 185-191

  Yu, Ming ^a,b   Sato, Hiroshi ^c   Seiki, Motoharu ^c,d   Spiegel, Sarah ^a,b   Thompson, Erik W ^a,e  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c KANAZAWA UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Activation; cAMP; Concanavalin A; Gelatinasa A; Human breast cancer; MT MMP

Indexed keywords

CONCANAVALIN A; CYCLIC AMP; MATRIX METALLOPROTEINASE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; ENZYME INDUCTION; ENZYME INHIBITION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PHOSPHATE METABOLISM; PROTEIN PROCESSING; TRANSCRIPTION REGULATION;

EID: 0031800674     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006580406314     Document Type: Article

References (30)

1. Woessner JF, Jr, 1991, Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J, 5, 2145-54.
2. Birkedal-Hansen H, Moore WG, Bodden MK, et al. 1993, Matrix metalloproteinases: a review. Crit Rev Oral Biol Med, 4, 197-250.
3. Stetler-Stevenson WG, Liotta LA and Kleiner DE, 1993, Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J, 7, 1434-41.
4. Heppner KJ, Matrisian LM, Jensen RA and Rodgers WH, 1996, Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol, 149, 273-82.
5. Polette M and Birembaut P, 1996, Matrix metalloproteinases in breast cancer. The Breast Journal, 2, 209-20.
6. Davies B, Miles DW, Happerfield LC, et al. 1993, Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer, 67, 1126-31.
7. Lee K, Rha S, Kim S, et al. 1996, Sequential activation and production of matrix metalloproteinase-2 during breast cancer progression. Clin Exp Metastasis, 14, 512-19.
8. Sato H and Seiki M, 1996, Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. J Biochem (Tokyo), 119, 209-15.
9. Okada A, Bellocq JP, Rouyer N, et al. 1995, Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA, 92, 2730-4.
10. Polette M, Nawrocki B, Gilles C, et al. 1996, MT-MMP expression and localisation in human lung and breast cancers. Virchows Arch Int J Pathol, 428, 29-35.
11. Gilles C, Polette M, Birembaut P and Thompson EW, 1997, Collagen type I-induced MT1-MMP expression and MMP-2 activation: implication in the metastatic progression of breast carcinoma. Lab Invest, 76, 651-60.
12. Maniatis T, Fritsch EF and Sambrook J, 1982, Molecular Cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
13. Ueno H, Nakamura H, Inoue M, et al. 1997, Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast cancers. Cancer Res, 57, 2055-60.
14. Yu M, Sato H, Seiki M and Thompson EW, 1995, Complex regulation of membrane-matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells. Cancer Res, 55, 3272-7.
15. Pulyaeva H, Washington D, Bueno J, et al. 1997. MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells. Clin Exp Metastasis, 15, 111-20.
16. Maiti SN, Yu M, Bueno J, et al. 1994, Differential regulation of matrix metalloproteinase-2 activation in human breast cancer cell lines. Ann NY Acad Sci, 732, 456-8.
17. Sato H, Takino T, Okada Y, et al. 1994, A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature, 370, 61-5.
18. Brooks PC, Strömblad S, Sanders LC, et al. 1996, Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell, 85, 683-93.
19. Ailenberg M and Silverman M, 1996, Cellular activation of mesangial gelatinase A by cytochalasin D is accompanied by enhanced mRNA expression of both gelatinase A and its membrane-associated gelatinase A activator (MT-MMP). Biochem J, 313, 879-84.
20. Sato H, Takino T, Kinoshita T, et al. 1996, Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP). FEBS Lett, 385, 238-40.
21. Lohi J, Lehti K, Westermarck J, Kahari VM and Keski-Oja J, 1996, Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur J Biochem, 239, 239-47.
22. Yu M, Sato H, Seiki M, Spiegel S and Thompson EW, 1997, Calcium influx inhibits MT1-MMP processing and blocks MMP-2 activation. FEBS Lett, 412, 568-72.
23. Keski-Oja J, Lehti J and Lohi J, 1977, Proteolytic activation of membrane-type matrix metalloproteinase-1. Proc Am Assn Cancer Res, 38, 166 (abstract).
24. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA and Goldberg GI, 1995, Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem, 270, 5331-8.
25. Horgan AF, O'Riordain DS, Chin DH, Mannick JA and Rodrick ML, 1994, The role of cyclic adenosine monophosphate in the suppression of cellular immunity after thermal injury. Arch Surg, 129, 1284-9.
26. Uotila P, 1996, The role of cyclic AMP and oxygen intermediates in the inhibition of cellular immunity in cancer. Cancer Immunol Immunother, 43, 1-9.
27. Corcoran ML, Stetler-Stevenson WG, De Witt DL and Wahl LM, 1994, Effect of cholera toxin and pertussis toxin on prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinase production by human monocytes. Arch Biochem Biophys, 310, 481-8.
28. Borger P, Kauffman HF, Postma DS and Vellenga E, 1996, Interleukin-4 gene expression in activated human T lymphocytes is regulated by the cyclic adenosine monophosphate-dependent signaling pathway. Blood, 87, 691-8.
29. Borger P, Kauffman HF, Vijgen JL, Postma DS and Vellenga E, 1996, Activation of the cAMP-dependent signaling pathway downregulates the expression of interleukin-3 and granulocyte-macrophage colony-stimulating factor in activated human T lymphocytes. Exp Hematol, 24, 108-15.
30. Iyengar R, 1996, Gating by cyclic AMP: expanded role for an old signaling pathway. Science, 271, 461-3.